Intrinsic Value of S&P & Nasdaq Contact Us

Karuna Therapeutics, Inc. KRTX NASDAQ

NASDAQ Global Market • Healthcare • Biotechnology • US • USD

SharesGrow Score
27/100
1/7 Pass
SharesGrow Intrinsic Value
N/A
Negative cash flow
Analyst Price Target
$257.50
-21.9%

Karuna Therapeutics, Inc. (KRTX) has 20 known insider and institutional holders on record. The largest holder is PureTech Health LLC with 2,406,564 shares. Other notable holders include Lykins Charmaine and PAUL STEVEN M.

KRTX Insider Ownership

Top Holder
PureTech Health LLC
2,406,564 shares
Buys (12 mo)
0
$0.00 value
Sells (12 mo)
0
$0.00 value
Top Insider Holders
# Name Role Shares Owned Last Filed Relative Size
1 Puretech Health Llc Officer 2,406,564 2021-02-10
100%
2 Lykins Charmaine Chief Commercial Officer 75,000 2021-11-30
3%
3 Paul Steven M Director 70,608 2024-03-04
3%
4 Harrigan Edmund Director 55,163 2020-08-14
2%
5 Meury William President and CEO 38,688 2024-02-15
2%
6 Ignelzi Troy A. Chief Financial Officer 30,487 2023-08-24
1%
7 Miller Andrew Craig President of R&d 15,855 2024-02-15
1%
8 Kane William P Jr Chief Commercial Officer 10,306 2024-02-15
0%
9 Brown Jason Parker Chief Financial Officer 10,306 2024-02-15
0%
10 Preston Heather Director 6,556 2021-06-28
0%
11 Nelsen Robert 10 Percent Owner 5,269 2021-04-15
0%
12 Chowrira Bharat M Director 5,000 2019-07-02
0%
13 Brannan Stephen K. Chief Medical Officer 4,677 2024-03-11
0%
14 Healy James Director 1,904 2023-06-22
0%
15 Coughlin Christopher J Director 990 2023-06-22
0%
16 Wheadon David E. Director 990 2023-06-22
0%
17 Olson Laurie J Director 990 2023-07-05
0%
18 Torres Denice Director 990 2023-06-22
0%
19 Jonas Jeffrey M Director 990 2023-09-05
0%
20 Pande Atul Director 990 2023-06-22
0%

No ownership data available for KRTX.

Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
Send us a message